ARTIFICIAL INTELLIGENCE IN EARLY DIAGNOSIS OF NEURODEGENERATIVE DISEASES: CURRENT EVIDENCE AND PROSPECTS

Authors

  • Norkulova Dilnura Ulugbekovnaz Medical Prevention, Group 202 Author
  • Sirojova Guldona Gayrat qizi General Medicine, Group 144 Author
  • Ulug'murodov Shohzod Bekzodovich General Medicine, Group 169 Author
  • Karimova Lobar Rustam qizi Faculty of Pediatrics, Group 209 Author
  • Muxammadjonov Lochinbek Faculty of General Medicine No. 1, Group 322 Author

Abstract

Neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), represent a growing global health burden, with millions of individuals affected worldwide and limited disease-modifying therapies available. Early and accurate diagnosis is critical for improving patient outcomes, yet conventional diagnostic approaches often fail to detect pathological changes prior to overt symptom onset. Artificial intelligence (AI), particularly machine learning (ML) and deep learning (DL) methodologies, has demonstrated remarkable promise in transforming early diagnostic paradigms through the analysis of neuroimaging, genetic, clinical, and digital biomarker data.

Downloads

Published

2026-05-13

Issue

Section

Articles

How to Cite

ARTIFICIAL INTELLIGENCE IN EARLY DIAGNOSIS OF NEURODEGENERATIVE DISEASES: CURRENT EVIDENCE AND PROSPECTS. (2026). Educator Insights: Journal of Teaching Theory and Practice, 2(5), 104-113. https://brightmindpublishing.com/index.php/EI/article/view/2594